{"id":4345,"date":"2018-05-21T16:41:26","date_gmt":"2018-05-21T20:41:26","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=4345"},"modified":"2018-05-21T17:09:14","modified_gmt":"2018-05-21T21:09:14","slug":"secondaries-announced-5-21-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-5-21-18\/","title":{"rendered":"Secondaries Announced 5.21.18"},"content":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis.<\/strong><\/h4>\n

If having\u00a0real-time alerts for secondary offerings<\/strong><\/a>\u00a0would be an advantage to you,\u00a0inquire about a subscription today!<\/a><\/p>\n

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.<\/p>\n

Company: Plymouth REIT
\nSymbol: PLYM
\nPrice: Last Trade $17.88
\nTrade Date: 5\/25
\nShares: 4.25 million
\nUnderwriter(s): Sandler O\u2019 Neill + Partners, D.A. Davidson & Co.
\nCo-Manager(s): BB&T Capital, National Securities, American Capital Partners
\nDescription: They are a full service, vertically integrated, self-administered and self-managed Maryland corporation focused on the acquisition, ownership and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses and light industrial properties, primarily located in secondary and select primary markets across the United States.
\nRating =\u00a0Subscription Needed<\/a><\/strong><\/p>\n

Company: USA Technologies Inc
\nSymbol: USAT
\nPrice: Last Trade $11.70
\nTrade Date: 5\/23
\nShares: 4.7 million
\nUnderwriter(s): William Blair
\nCo-Manager(s): Craig Hallum, Northland Capital, Barrington Research
\nDescription: The company provides wireless networking, cashless transactions, asset monitoring, and other value-added services principally to the small ticket, unattended Point of Sale market.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: MyoKardia, Inc.
\nSymbol: MYOK
\nPrice: Last Trade $48.35
\nTrade Date: 5\/23
\nShares: 3.75 million
\nUnderwriter(s): J.P. Morgan, BofA Merrill Lynch, Credit Suisse, Wells Fargo
\nDescription: MyoKardia is a clinical-stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and rare cardiovascular diseases.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Ardelyx, Inc.
\nSymbol: ARDX
\nPrice: Last Trade $5.65
\nTrade Date: 5\/23
\nShares: 8.9 million ($50m cash raise)
\nUnderwriter(s): Jefferies, Leerink Partners
\nDescription: Ardelyx is focused on enhancing the way people with renal diseases are treated by developing first-in-class medicines.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Melinta Therapeutics, Inc.
\nSymbol: MLNT
\nPrice: Last Trade $7.30
\nTrade Date: 5\/24
\nShares: 10.3 million ($75 million cash raise)
\nUnderwriter(s): J.P. Morgan, Jefferies
\nCo-Manager(s): Cantor
\nDescription: They are a commercial-stage pharmaceutical company focused on discovering, developing and commercializing differentiated anti-infectives for the hospital and select non-hospital, or community, settings that address the need for effective treatments for infections due to resistant gram-negative and gram-positive bacteria.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Coherus BioSciences
\nSymbol: CHRS
\nPrice: Last Trade $15.25
\nTrade Date: 5\/23
\nShares: 4.9 million ($75m cash raise)
\nUnderwriter(s): J.P. Morgan, Citigroup
\nCo-Manager(s): Baird, H.C. Wainwright & Co., Maxim Group
\nDescription: Coherus is a U.S. based integrated development and commercialization biologics company, focused on biosimilars.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: SailPoint Technologies Holdings
\nSymbol: SAIL
\nPrice: Last Trade $22.44
\nTrade Date: 5\/24
\nShares: 15 million
\nUnderwriter(s): Morgan Stanley, Goldman Sachs, Citigroup, Jefferies, RBC Capital
\nCo-Manager(s): KeyBanc Capital, Piper Jaffray, Canaccord Genuity, Oppenheimer & Co., BTIG
\nDescription: SailPoint is a leading provider of enterprise identity governance solutions.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: FB Financial Corporation
\nSymbol: FBK
\nPrice: Last Trade $43.64
\nTrade Date: 5\/23
\nShares: 3.2 million
\nUnderwriter(s): J.P. Morgan, Stephens Inc.
\nDescription: They are a bank holding company headquartered in Nashville, Tennessee.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: 2U, Inc.
\nSymbol: TWOU
\nPrice: Last Trade $95.93
\nTrade Date: 5\/23
\nShares: 3.2 million ($300 million cash raise)
\nUnderwriter(s): Goldman Sachs, Credit Suisse, Citigroup
\nCo-Manager(s): Compass Point, KeyBanc Capital, Macquarie Capital
\nDescription: 2U partners with great colleges and universities to build what we believe is the world’s best digital education.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Benefitfocus, Inc.-BLOCK
\nSymbol: BNFT
\nPrice: Last Trade $35.25
\nTrade Date: 5\/22
\nRe-offer Range: $33.50-$34.00
\nShares: 2.5 million
\nUnderwriter(s): JP Morgan
\nDescription: They unifies the entire U.S. benefits industry on a single technology platform to protect consumers\u2019 health, wealth and lifestyle.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: RealPage, Inc.
\nSymbol: RP
\nPrice: Last Trade $59.50
\nTrade Date: 5\/24
\nShares: 6.5 million
\nUnderwriter(s): Morgan Stanley, J.P. Morgan, RBC Capital
\nCo-Manager(s): JMP Securities, KeyBanc Capital, Fifth Third Securities
\nDescription: RealPage is a leading global provider of software and data analytics to the real estate industry.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Cadence Bancorporation
\nSymbol: CADE
\nPrice: Last Trade $29.05
\nTrade Date: 5\/23
\nShares: 15 million
\nUnderwriter(s): Goldman Sachs, J.P. Morgan, Morgan Stanley, Keefe Bruyette & Woods, Sandler O\u2019Neill, Barclays, RBC
\nCo-Manager(s): Stephens, Inc.
\nDescription: Cadence Bancorporation is a $11 billion in assets regional bank holding company headquartered in Houston, Texas.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis. If having\u00a0real-time alerts for secondary offerings\u00a0would be an advantage to you,\u00a0inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[],"class_list":["post-4345","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=4345"}],"version-history":[{"count":3,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4345\/revisions"}],"predecessor-version":[{"id":4348,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4345\/revisions\/4348"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=4345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=4345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=4345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}